Page last updated: 2024-08-23

1-deoxynojirimycin and Bilharziasis

1-deoxynojirimycin has been researched along with Bilharziasis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dong, H; Liu, M; Wang, S; Xiang, T; Yang, K; Zhang, XL; Zhou, YD	1

Other Studies

1 other study(ies) available for 1-deoxynojirimycin and Bilharziasis

Article	Year
An iminosugar N-pentafluorobenzyl-1-deoxynojirimycin as a novel potential immunosuppressant for the treatment of Th2-related diseases. Bioorganic & medicinal chemistry letters, 2012, Jan-01, Volume: 22, Issue:1 Topics: 1-Deoxynojirimycin; Animals; Benzyl Compounds; CD4-Positive T-Lymphocytes; Chemistry, Pharmaceutical; Cyclosporine; Cytoplasm; Drug Design; Gene Expression Regulation; Humans; Immunosuppressive Agents; Interleukin-4; Leukocytes, Mononuclear; Mice; Models, Chemical; Schistosoma japonicum; Schistosomiasis; Signal Transduction; Spleen; Th2 Cells; Time Factors	2012

Article

Year

An iminosugar N-pentafluorobenzyl-1-deoxynojirimycin as a novel potential immunosuppressant for the treatment of Th2-related diseases.

Bioorganic & medicinal chemistry letters, 2012, Jan-01, Volume: 22, Issue:1

Topics: 1-Deoxynojirimycin; Animals; Benzyl Compounds; CD4-Positive T-Lymphocytes; Chemistry, Pharmaceutical; Cyclosporine; Cytoplasm; Drug Design; Gene Expression Regulation; Humans; Immunosuppressive Agents; Interleukin-4; Leukocytes, Mononuclear; Mice; Models, Chemical; Schistosoma japonicum; Schistosomiasis; Signal Transduction; Spleen; Th2 Cells; Time Factors

2012